Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine?

Vaccine

Volumn 28, Issue 1, 2009, Pages 207-227

  Zijtregtop, E A M ^a,b   Wilschut, J ^a   Koelma, N ^a   Van Delden, J J M ^b   Stolk, R P ^a   Van Steenbergen, J ^c   Broer, J ^d   Wolters, B ^d   Postma, M J ^a,e   Hak, E ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d Municipal Public Health Service Groningen   (Netherlands)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Education; Pandemic influenza vaccination; Prevention

Indexed keywords

AVIAN INFLUENZA VACCINE; INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AVIAN INFLUENZA; DEMOGRAPHY; FEMALE; HEALTH BEHAVIOR; HEALTH CARE PLANNING; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; MALE; MEXICO; NETHERLANDS; PANDEMIC; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEASONAL VARIATION; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE OUTBREAKS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; VACCINATION; YOUNG ADULT;

EID: 70749119494     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.099     Document Type: Article

References (21)

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360 25 (2009) 2605-2615
2. Flu Tracker. http://flutracker.rhizalabs.com/ [accessed 15.09.2009].
3. World Health Organisation. Cumulative number of conformed human cases of avian influenza A/(H5N1) reported to WHO (2, 2009). http://www.who.int/csr/disease/avian_influenza/country/cases_table_2009_ 06_02/en/index.html
4. Zwart de O., Veldhuizen I.K., Elam G., Aro A.R., Abraham T., Bishop G.D., et al. Avian influenza, risk perception, Europe and Asia. Emerg Infect Dis 13 2 (2007) 290-293
5. Sadique M.Z., Edmunds W.J., Smith R.D., Meerding W.J., de Zwart O., Brug J., et al. Precautionary behavior in response to perceived threat of pandemic influenza. Emerg Infect Dis 13 9 (2007) 1307-1313
6. Schwartz B., and Gellin B. Vaccination strategies for an influenza pandemic. J Infect Dis 191 (2005) 1207-1209
7. Jennings L.C., Monto A.S., Chan P.K.S., Szucs T.D., and Nicholson K.G. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Lancet Infect Dis 8 (2008) 650-658
8. Jong J.C., and Osterhaus A.D.M.E. Het eerste in Europa geregistreerde humane vaccine tegen de hoogpathogene vorm van een vogelgriepvirus: overwegingen. Ned Tijdschr Geneeskd 152 39 (2008) 2113-2115 [with summary in English]
9. Schwartz B., and Worthly P. Mass vaccination for annual and pandemic influenza. Mass vaccination: global aspects-progress and obstacles (2006), Springer, Berlin/Heidelberg p. 131-52
10. Sherif B., and Mossad M.D. Influenza update 2007-2008: vaccine advances, pandemic preparation. Clev Clin J Med 74 12 (2007) 889-894
11. World Health Organisation Writing Group. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis [Serial on the Internet] January (2006). http://www.cdc.gov/nciodod/EID/vol12no01/05-1371.htm Available at http://www.cdc.gov/nciodod/EID/vol12no01/05-1371.htm [accessed 15.06.2009]
12. World Health Organisation Writing Group. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis [Serial on the Internet] January (2006). http://www.cdc.gov/nciodod/EID/vol12no01/05-1370.htm Available at http://www.cdc.gov/nciodod/EID/vol12no01/05-1370.htm [accessed 15.06.2009]
13. RIVM. Vaccinatiegraad RVP (2008). http://www.rivm.nl/rvp/vaccineren/nl_vaccinatie/ [accessed 15.06.2009]
14. CBS. Griepvaccinatie naar leeftijd, geslacht en risicogroep (2007). [accessed 15.06.2009] http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=37471&D1= 0-7,17&D2=1-12&VW=T
15. Looijmans-van den Akker I., van den Heuvel P.M., Verheij T.J., van Delden J.J., van Essen G.A., and Hak E. No intention to comply with influenza and pneumococcal vaccination: behavioural determinants among smokers and non-smokers. Prev Med 45 5 (2007) 380-385
16. Looijmans-Akker van den I., van Delden J.J.M., Hulscher M.E., Verheij Th.J.M., Essen G.A., van der Sande M.A.B., et al. Which determinants should be targeted to increase influenza vaccination uptake among health care workers in nursing homes?. Vaccine (2009) [Epub ahead of print]
17. Rosenstock I.M. The health belief model and preventive health behavior. In: Beker M.A. (Ed). The health belief model and personal health behavior (1974), Charles B. Slack, Thorofare 27-59
18. Fishbein M., and Azjen I. Belief, attitude, intention and behaviour: an introduction to theory and research (1975), Addison-Wesley, Reading
19. Kroneman M.W., van Essen G.A., Tacken M.A., Paget W.J., and Verheij R. Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine 22 17-18 (2004) 2163-2170
20. Opstelten W., Essen van G.A., and Hak E. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly. Vaccine 27 2 (2009) 192-196
21. Opstelten W., van Steenbergen J.E., van Essen G.A., and van der Sande M.A. Threat of an influenza pandemic: family physicians in the front line. BMC Fam Pract 10 February (2009) 11